The United Nations Conference on Trade and Development has reportedly encouraged Bangladesh to open its markets, particularly its pharmaceutical industry, to foreign investment should the nation wish to continue its economic development.
According to reports, UNCTAD concluded its sixth session of its Investment, Enterprise and Development Commission on Friday to promote entrepreneurship and technological innovation.
The session included the presentation of UNCTAD’s investment policy review of Bangladesh, concluding that the nation has “an enormous potential” to attract foreign direct investment considering its strategic position between two emerging markets, among other benefits.
UNCTAD reportedly recommended investment policy reforms and, in particular, to relax is pharmaceutical regulation that has largely weakened foreign investment in the industry.
Bangladesh reportedly said it would carefully review the recommendations.
Full content: Intellectual Property Watch
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Car Battery Makers to Challenge EU Cartel Charges in Brussels
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI